METHOD FOR EVALUATION OF COMPOUND USING RSK1

摘要

A method for evaluation of a compound comprising the steps of introducing an RSK1 gene into a cell to prepare a cell capable of expressing RSK1, contacting a compound to be evaluated with the cell, and detecting the specific binding of the compound to RSK1; and a compound given by the method. The compound can be used as a potentiator or cisplatin. The method enables to find a gene which acts specifically on a cell of cancer induced by the abnormality of p53 or enhanced MAPK pathway and to evaluate a compound by using the gene.